Your browser doesn't support javascript.
loading
Identification of patients at high risk of secondary extramedullary multiple myeloma development.
Stork, Martin; Sevcikova, Sabina; Minarik, Jiri; Krhovska, Petra; Radocha, Jakub; Pospisilova, Lenka; Brozova, Lucie; Jarkovsky, Jiri; Spicka, Ivan; Straub, Jan; Pavlicek, Petr; Jungova, Alexandra; Jelinek, Tomas; Sandecka, Viera; Maisnar, Vladimir; Hajek, Roman; Pour, Ludek.
Afiliação
  • Stork M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Sevcikova S; Babak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Minarik J; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
  • Krhovska P; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
  • Radocha J; 4th Department of Internal Medicine - Hematology, Faculty Hospital and Charles University in Hradec Kralove, Hradec Kralove, Czech Republic.
  • Pospisilova L; Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic.
  • Brozova L; Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic.
  • Jarkovsky J; Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic.
  • Spicka I; 1st Medical Department - Clinical Department of Haematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic.
  • Straub J; Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Pavlicek P; Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Jungova A; Hematology and Oncology Department, Charles University Hospital, Pilsen, Czech Republic.
  • Jelinek T; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Sandecka V; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Maisnar V; 4th Department of Internal Medicine - Hematology, Faculty Hospital and Charles University in Hradec Kralove, Hradec Kralove, Czech Republic.
  • Hajek R; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
Br J Haematol ; 196(4): 954-962, 2022 02.
Article em En | MEDLINE | ID: mdl-34726261
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Idioma: En Ano de publicação: 2022 Tipo de documento: Article